AeroLeads people directory · profile
Simon Bruce Email & Phone Number
Vice-President, Internal Medicine at ICON plc
at
ICON plc
1 work email found
@iconplc.com
LinkedIn matched
✓ Verified Jun 2026
4 data sources
Profile completeness 100%
Current company
Role
Vice-President, Internal Medicine at ICON plc
Location
San Diego, California, United States
Company size
Who is Simon Bruce? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Simon Bruce is listed as Vice-President, Internal Medicine at ICON plc at ICON plc, a company with 33970 employees, based in San Diego, California, United States. AeroLeads shows a work email signal at iconplc.com and a matched LinkedIn profile for Simon Bruce.
Simon Bruce previously worked as Vice-President, Internal Medicine at Icon Plc and BioPharma Consultant, Clinical Development at Kinexum Services Llc. Simon Bruce holds Board Eligible In Endocrinology, Endocrinology from National Institutes Of Health.
Company email context
Email format at ICON plc
This section adds company-level context without repeating Simon Bruce's masked contact details.
{first}.{last}@iconplc.com
89% confidence
AeroLeads found 1 current-domain work email signal for Simon Bruce. Compare company email patterns before reaching out.
Profile bio
About Simon Bruce
Simon Bruce is a Vice-President, Internal Medicine at ICON plc at ICON plc. He possess expertise in clinical development, clinical trials, diabetes, clinical research, medical affairs and 22 more skills.
Listed skills include Clinical Development, Clinical Trials, Diabetes, Clinical Research, and 23 others.
Current workplace
Simon Bruce's current company
Company context helps verify the profile and gives searchers a useful next step.
Icon Plc
10 roles · 26 years
Simon Bruce work experience
A career timeline built from the work history available for this profile.
May 2021 - Present
Biopharma Consultant, Clinical Development
CurrentKinexum TRANSLATIONAL RESEARCH & STRATEGIC SERVICES - "Kinexum guides, designs, and manages strategic and operational solutions to the regulatory, manufacturing, nonclinical, clinical development, and business challenges necessary to take scientific discoveries to proof of concept and through the product life cycle" - kinexum.com
Feb 2017 - Present
Vice-President, Clinical Development
Calcilytix (Subsidiary Of Bridgebio)
Led clinical development of orphan drug indication in hypoparathyroidism for a calcium-sensing receptor antagonist including through CRADA with NIH intramural investigators. Developed innovative Phase 1/2 trial accepted by FDA and NIH for streamlined dose-finding and proof-of concept. Worked with small cross-functional team of veteran drug developers and.
Mar 2019 - Apr 2020
Chief Medical Officer
Dec 2014 - Feb 2017
Executive Medical Director, Endocrinology
Nov 2012 - Nov 2014
Executive Director, Global Program Medical Director
Executive Director in the Metabolics Clinical Science Unit - Supervise physician and clinical scientist in a small team acting as main interface from late-stage clinical development with colleagues across all metabolic programs in translational medicine. Acting as a liaison to help bridge the perennial potential gaps between early development and full.
2010 - Dec 2012
Sr. Medical Director
Increasing levels of responsibility including managing team of PhD's in Health Economics and Outcomes Research, Pharmacometrics, safety surveillance, investigator initiated trials programs, and a group of scientists responsible for clinical/pre-clinical interface including key assays for development program biologics. Initiated and designed an IND trial in.
Mar 2007 - Oct 2011
Sr. Medical Director, Clinical Development
Medical Lead for novel fructose 1,6 bisphophatase inhibitor designed to block overactive gluconeogenesis which is recognized to be a fundamental pathophysiology in type 2 diabetes. Soon after joining a concurrent clinical pharmacology study revealed a propensity for lactic acidosis when combined with metformin. Negotiated directly with FDA medical reviewer.
Feb 2005 - Mar 2007
Medical Director, Clinical Development
Medical Lead for DPP4 inhibitor, Saxagliptin, from pre-IND stage through to Phase 3.Initially worked as medic on Phase 3b/4 portfolio of studies supporting the first oral combination pill for type 2 diabetes, Glucovance. Managed multimillion clinical development budget. Worked in close alignment with medical affairs and supervised a team of up to 15.
2000 - 2005
~5 yrs
Team & coworkers
Colleagues at ICON plc
Other employees you can reach at iconplc.com. View company contacts for 33970 employees →
KD
Kerem Dülekçayır
Colleague at Icon PlcIstanbul, Istanbul, Türkiye, Turkey
View →
SR
Swetha Reddy
Colleague at Icon PlcHyderabad, Telangana, India, India
View →
AD
Anushree Dey
Colleague at Icon PlcBengaluru, Karnataka, India, India
View →
KD
Kelly D.
Colleague at Icon PlcCity Of Johannesburg, Gauteng, South Africa, South Africa
View →
SP
Sylvie Praud
Colleague at Icon PlcCorbas, Auvergne-Rhône-Alpes, France, France
View →
I(
Idorenyin (Idy) Godfrey
Colleague at Icon PlcCedar Hill, Texas, United States, United States
View →
EM
Eleni Marofidou
Colleague at Icon PlcUnited Kingdom, United Kingdom
View →
KC
Kanushana Chivananthan
Colleague at Icon PlcUnited Kingdom, United Kingdom
View →
BM
Bev Mclean
Colleague at Icon PlcGreater Swansea Area, United Kingdom
View →
JM
Jacqueline M.
Colleague at Icon PlcRaleigh-Durham-Chapel Hill Area, United States
View →
Kerem Dülekçayır
Colleague at Icon PlcIstanbul, Istanbul, Türkiye, Turkey
View →
SR
Swetha Reddy
Colleague at Icon PlcHyderabad, Telangana, India, India
View →
AD
Anushree Dey
Colleague at Icon PlcBengaluru, Karnataka, India, India
View →
KD
Kelly D.
Colleague at Icon PlcCity Of Johannesburg, Gauteng, South Africa, South Africa
View →
SP
Sylvie Praud
Colleague at Icon PlcCorbas, Auvergne-Rhône-Alpes, France, France
View →
I(
Idorenyin (Idy) Godfrey
Colleague at Icon PlcCedar Hill, Texas, United States, United States
View →
EM
Eleni Marofidou
Colleague at Icon PlcUnited Kingdom, United Kingdom
View →
KC
Kanushana Chivananthan
Colleague at Icon PlcUnited Kingdom, United Kingdom
View →
BM
Bev Mclean
Colleague at Icon PlcGreater Swansea Area, United Kingdom
View →
JM
Jacqueline M.
Colleague at Icon PlcRaleigh-Durham-Chapel Hill Area, United States
View →
2 education records
Simon Bruce education
Board Eligible In Endocrinology, Endocrinology
National Institutes Of Health
Bs, Neuroscience
Yale University
FAQ
Frequently asked questions about Simon Bruce
Quick answers generated from the profile data available on this page.
What company does Simon Bruce work for?
Simon Bruce works for ICON plc.
What is Simon Bruce's role at ICON plc?
Simon Bruce is listed as Vice-President, Internal Medicine at ICON plc at ICON plc.
What is Simon Bruce's email address?
AeroLeads has found 1 work email signal at @iconplc.com for Simon Bruce at ICON plc.
Where is Simon Bruce based?
Simon Bruce is based in San Diego, California, United States while working with ICON plc.
What companies has Simon Bruce worked for?
Simon Bruce has worked for Icon Plc, Kinexum Services Llc, Calcilytix (Subsidiary Of Bridgebio), Adocia, and Halozyme Therapeutics, Inc..
Who are Simon Bruce's colleagues at ICON plc?
Simon Bruce's colleagues at ICON plc include Kerem Dülekçayır, Swetha Reddy, Anushree Dey, Kelly D., and Sylvie Praud.
How can I contact Simon Bruce?
You can use AeroLeads to view verified contact signals for Simon Bruce at ICON plc, including work email, phone, and LinkedIn data when available.
What schools did Simon Bruce attend?
Simon Bruce holds Board Eligible In Endocrinology, Endocrinology from National Institutes Of Health.
What skills is Simon Bruce known for?
Simon Bruce is listed with skills including Clinical Development, Clinical Trials, Diabetes, Clinical Research, Medical Affairs, Pharmaceutical Industry, Endocrinology, and Drug Development.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial